Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia
Clinical trial NCT00051298 · COMPLETED
Trial details
- NCT number
- NCT00051298
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.